A Planning Playbook for Opening a New Orthopedic ASC
The ASC market continues its rapid growth. In 2023, roughly 116 new ASCs opened in the U.S., many of which were orthopedic-specific in nature....
This website uses cookies. to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking “Accept & Close”, you consent to our use of cookies. Read our Privacy Policy to learn more.
By: Bill Meltzer
Published: 10/10/2007
Medicare Update
MedPAC Proposal Likely Won't Make Medicare Bill
The final Medicare reform bill in Congress won't likely incorporate the Medicare Payment Advisory Commission's (MedPAC) recommendation to cap ambulatory surgery center payments. Neither the House nor the Senate versions of the bill include the recommended provisions that would have reduced as many as 358 ASC payments to the hospital outpatient department (HOPD) rate for the same procedure. The news for ASCs is not all good.
MedPAC's suggested reimbursement freeze remains on the table, and Congress may introduce it in future legislation, says Eric Zimmerman, Esq. The provision also could wind up in the present legislation.
Secondly, the House version of the Medicare bill (section 625 of HR1) includes MedPAC's recommendation to reduce the annual inflation update for ASCs by 2 percent below the Consumer Price Index (CPI), restoring a provision of the 1996 Balanced Budget Amend-ment that was allowed to lapse last year. The House bill calls for no decrease in HOPD adjustments and a 0.4 percent decrease in inpatient services. The Senate version does not address ASC cost-of-living adjustments and would let ASCs keep their full annual inflationary adjustment.
|
Meanwhile, the Senate bill includes an amendment introduced by Sen. John Breaux (D-LA) that would ban physician-owned specialty hospitals. The House version calls for a MedPAC study of specialty hospitals before any law is proposed. Sen. Breaux is among the conferees who will resolve the discrepancies in the bills (see "Bracing for a Medicare Clampdown on Specialty Hospitals" on page 22).
Resolution of the bill is not expected until mid-October.
HIPAA Compliance
How Will CMS Enforce
HIPAA Coding Compliance?
The Centers for Medicare and Medicaid Services (CMS) will use a complaint-driven process to enforce new standards for coding and billing transactions set forth in the Health Insurance Portability and Accountability Act (HIPAA). The standards take effect Oct. 16.
If CMS gets a complaint about non-compliant coding, it will notify your facility in writing. To avoid punitive action, you must demonstrate a good-faith effort at compliance and submit a corrective action plan. In "good-faith" cases, CMS will not assess monetary penalties if there is reasonable cause for non-compliance, the non-compliance is not due to willful neglect of the HIPAA statute and if the problem is rectified within 30 days.
For more information on the HIPAA coding and billing standards, see "When Will Your Transactions Be HIPAA-Compliant?" on page 24. Visit www.cms.hhs.gov/hipaa/hipaa2/guidance-final.pdf for more information from the CMS website.
Refractive IOLs
Staar ICL on FDA Fast Track
Staar Surgical's Implantable Contact Lens (ICL) was accepted last month for substantive review by the FDA and granted expedited review status; the ICL is now one step from being used to treat myopia in the United States. The FDA grants expedited review when a device "represents a breakthrough in technology."
"The Staar ICL treats my-opic eyes in the range beyond what LASIK can treat, namely 10 diopters up to 20 diopters of near-sightedness," says Charles Post Jr., MD, of Plymouth Laser and Surgical Center in Massachusetts. "And it'll be available in lower powers, down to 1 or 2 diopters."
"[Surgeons] already doing temporal clear corneal surgery will find this to be an easy transition. It provides immediate good vision without invading the cornea or visual axis.," says Dr. Post, who learned to implant the Staar ICL in the Dominican Republic at a clinic run by Juan Batlle, MD.
This ICL Pre-Market Ap-proval Application (PMA) is for myopia; the phakic refractive lens also treats hyperopia and astigmatism. PMAs for those conditions are pending.
Financial Benchmarking
ASC Survey Reveals Profitability
Key findings from "Ambulatory Surgery Center Performance Survey," a benchmarking report based on 72 ASCs who responded to a Medical Group Management Association (MGMA) survey:
Outpatient Surgery 2020
Study: Surgical Demand Growing, Surgeon Availability Shrinking
The demand for surgery will grow by nearly 50 percent in some specialties by the year 2020, according to a study in the August Annals of Surgery by UCLA researchers. They cite the aging U.S. population and improvements in minimally invasive surgical technologies as the reasons.
The study predicts double-digit volume increases for all specialties. But the surgeon availability is waning.
The biggest demand increases are predicted in ophthalmology (47 percent), urology (35 percent), general surgery (31 percent), orthopedics (28 percent) and neurosurgery (28 percent). The smallest is in ENT surgery (14 percent).
HealthSouth
Silver Linings Possible in a Bankruptcy
Amid the chaos surrounding HealthSouth, there have been some silver linings for physician partners in HealthSouth's 203 outpatient facilities.
"The management of HealthSouth has actually been much more conducive to working with the doctors and being less centralized and authoritarian," says Randall Dryer, MD, the medical director at the HealthSouth Surgic-al Hospital of Austin in Texas.
HealthSouth could be pushed into bankruptcy, despite its reorganization plan, because of an expanded federal investigation. Its options include selling the less-profitable facilities or turning over assets to creditors.
Regardless of who is selling interests in ASCs, physicians are likely purchase candidates, says Gary W. Marsh, Esq., a partner at the Atlanta branch of McKenna, Long and Aldridge. "The interests are sold at fair market value, which is decided by the courts," says Mr. Marsh, who specializes in Chapter 11 bankruptcies. "But the value may be far less than it was when HealthSouth purchased it because of the scandal, the economy and changes in the market."
The ASC market continues its rapid growth. In 2023, roughly 116 new ASCs opened in the U.S., many of which were orthopedic-specific in nature....
In her 24 years as a nurse at Penn Medicine, Connie Croce has seen the evolution from open to laparoscopic to robotic surgery....
Through my decades of researching, testing and helping implement healthcare design solutions, I’ve learned an important lesson: A human-centered and evidence-based...